Ricardo Henao

Ricardo Henao

Auto-generated profile, based on publicly available information

Ricardo Henao

Department of Electrical and Computer Engineering Duke University

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Critical Care Medicine
Verified
Journal Article
Closed access
Timothy SweeneyTimothy Sweeney
Timothy Sweeney
TATej D Azad
Tej D Azad
MDMichele Donato
Michele Donato
WHWinston A. Haynes
Winston A. Haynes
TPThanneer M. Perumal
Thanneer M. Perumal
PKPurvesh Khatri
Purvesh Khatri
Objectives: To find and validate generalizable sepsis subtypes using data-driven clustering. Design: We used advanced informatics techniques to pool data from 14 bacterial sepsis transcriptomic datasets from eight different countries (n = 700). Setting: Retrospective analysis. Subjects: Persons admitted to the hospital with bacterial sepsis. Interventions: None. Measurements and Main Results: A unified clustering analysis across 14 discovery datasets revealed three subtypes, which, based on functional analysis, we termed “Inflammopathic, Adaptive, and Coagulopathic.” We then validated these subtypes in nine independent datasets from five different countries (n = 600). In both discovery and validation data, the Adaptive subtype is associated with a lower clinical severity and lower mortality rate, and the Coagulopathic subtype is associated with higher mortality and clinical coagulopathy. Further, these clusters are statistically associated with clusters derived by others in independent single sepsis cohorts. Conclusions: The three sepsis subtypes may represent a unifying framework for understanding the molecular heterogeneity of the sepsis syndrome. Further study could potentially enable a precision medicine approach of matching novel immunomodulatory therapies with septic patients most likely to benefit.

1 January 2018
Verified
Conference Paper
Open access
GWGuoyin Wang
Guoyin Wang
CLChunyuan Li
Chunyuan Li
WWWenlin Wang
Wenlin Wang
YZYizhe Zhang
Yizhe Zhang
DSDinghan Shen
Dinghan Shen
LCLarry Carin
Larry Carin

1 January 2018
Verified
Conference Paper
Closed access
DSDinghan Shen
Dinghan Shen
GWGuoyin Wang
Guoyin Wang
WWWenlin Wang
Wenlin Wang
MMMartin Renqiang Min
Martin Renqiang Min
QSQinliang Su
Qinliang Su
LCLarry Carin
Larry Carin

15 February 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
Timothy SweeneyTimothy Sweeney
Timothy Sweeney
TPThanneer M. Perumal
Thanneer M. Perumal
RHRicardo Henao
Ricardo Henao
MNMarshall Nichols
Marshall Nichols
JHJudith A. Howrylak
Judith A. Howrylak
RLRaymond Langley
Raymond Langley
Improved risk stratification and prognosis prediction in sepsis is a critical unmet need. Clinical severity scores and available assays such as blood lactate reflect global illness severity with suboptimal performance, and do not specifically reveal the underlying dysregulation of sepsis. Here, we present prognostic models for 30-day mortality generated independently by three scientific groups by using 12 discovery cohorts containing transcriptomic data collected from primarily community-onset sepsis patients. Predictive performance is validated in five cohorts of community-onset sepsis patients in which the models show summary AUROCs ranging from 0.765–0.89. Similar performance is observed in four cohorts of hospital-acquired sepsis. Combining the new gene-expression-based prognostic models with prior clinical severity scores leads to significant improvement in prediction of 30-day mortality as measured via AUROC and net reclassification improvement index These models provide an opportunity to develop molecular bedside tests that may improve risk stratification and mortality prediction in patients with sepsis.

20 January 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
ETEphraim L. Tsalik
Ephraim L. Tsalik
RHRicardo Henao
Ricardo Henao
MNMarshall Nichols
Marshall Nichols
TBThomas Burke
Thomas Burke
EKEmily R. Ko
Emily R. Ko
CWChristopher Wildrick Woods
Christopher Wildrick Woods
Acute respiratory infections caused by bacterial or viral pathogens are among the most common reasons for seeking medical care. Despite improvements in pathogen-based diagnostics, most patients receive inappropriate antibiotics. Host response biomarkers offer an alternative diagnostic approach to direct antimicrobial use. This observational cohort study determined whether host gene expression patterns discriminate noninfectious from infectious illness and bacterial from viral causes of acute respiratory infection in the acute care setting. Peripheral whole blood gene expression from 273 subjects with community-onset acute respiratory infection (ARI) or noninfectious illness, as well as 44 healthy controls, was measured using microarrays. Sparse logistic regression was used to develop classifiers for bacterial ARI (71 probes), viral ARI (33 probes), or a noninfectious cause of illness (26 probes). Overall accuracy was 87% (238 of 273 concordant with clinical adjudication), which was more accurate than procalcitonin (78%, P < 0.03) and three published classifiers of bacterial versus viral infection (78 to 83%). The classifiers developed here externally validated in five publicly available data sets (AUC, 0.90 to 0.99). A sixth publicly available data set included 25 patients with co-identification of bacterial and viral pathogens. Applying the ARI classifiers defined four distinct groups: a host response to bacterial ARI, viral ARI, coinfection, and neither a bacterial nor a viral response. These findings create an opportunity to develop and use host gene expression classifiers as diagnostic platforms to combat inappropriate antibiotic use and emerging antibiotic resistance.

23 August 2022 in JID Innovations
Verified
Journal Article
Open access
HJHyeon Ki Jeong
Hyeon Ki Jeong
CPChristine Park
Christine Park
RHRicardo Henao
Ricardo Henao
MKMeenal Kheterpal
Meenal Kheterpal
Artificial intelligence (AI) has recently made great advances in image classification and malignancy prediction in the field of dermatology. However, understanding the applicability of AI in clinical dermatology practice remains challenging owing to the variability of models, image data, database characteristics, and variable outcome metrics. This systematic review aims to provide a comprehensive overview of dermatology literature using convolutional neural networks. Furthermore, the review summarizes the current landscape of image datasets, transfer learning approaches, challenges, and limitations within current AI literature and current regulatory pathways for approval of models as clinical decision support tools.